These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3491804)

  • 21. Efficacy of a novel chelator BPCBG for removing uranium and protecting against uranium-induced renal cell damage in rats and HK-2 cells.
    Bao Y; Wang D; Li Z; Hu Y; Xu A; Wang Q; Shao C; Chen H
    Toxicol Appl Pharmacol; 2013 May; 269(1):17-24. PubMed ID: 23454449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the efficiency of DTPA and other new chelating agents for removing neptunium from target organs.
    Paquet F; Metivier H; Poncy JL; Burgada R; Bailly T
    Int J Radiat Biol; 1997 May; 71(5):613-21. PubMed ID: 9191906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Removal of Pu and am from beagles and mice by 3,4,3-LICAM(C) or 3,4,3-LICAM(S).
    Lloyd RD; Bruenger FW; Mays CW; Atherton DR; Jones CW; Taylor GN; Stevens W; Durbin PW; Jeung N; Jones ES
    Radiat Res; 1984 Jul; 99(1):106-28. PubMed ID: 6547537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neptunium--the neglected actinide: corrections and extensions.
    Thompson RC
    Radiat Res; 1982 Dec; 92(3):620-1. PubMed ID: 7178426
    [No Abstract]   [Full Text] [Related]  

  • 25. Age-related efficiency of Ca-DTPA to reduce 141Ce retention in rats.
    Kargacin B; Kostial K
    Toxicol Lett; 1986 Sep; 32(3):243-7. PubMed ID: 3775807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chelation of 238Pu(IV) in vivo by 3,4,3-LICAM(C): effects of ligand methylation and pH.
    Durbin PW; White DL; Jeung NL; Weitl FL; Uhlir LC; Jones ES; Bruenger FW; Raymond KN
    Health Phys; 1989 Jun; 56(6):839-55. PubMed ID: 2722507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal absorption of neptunium in primates: effect of ingested mass, diet, and fasting.
    Metivier H; Bourges J; Fritsch P; Nolibe D; Masse R
    Radiat Res; 1986 May; 106(2):190-200. PubMed ID: 3704111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of the mass and initial chemical form of neptunium on its molecular associations in blood and liver.
    Paquet F; Ramounet B; Métivier H; Taylor DM
    Radiat Res; 1996 Sep; 146(3):306-12. PubMed ID: 8752309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PREVENTION OF PLUTONIUM AND NEPTUNIUM DEPOSITION. HW-76000.
    SMITH VH
    HW SA US At Energy Comm; 1963 Jan; 86():143-8. PubMed ID: 24547059
    [No Abstract]   [Full Text] [Related]  

  • 30. Factors influencing the efficiency of chelation therapy.
    Kostial K; Kargacin B; Arezina R; Landeka M; Simonović I
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(4):337-50. PubMed ID: 1804865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of mixed-ligand complexes on retention and distribution of radioniobium in mice.
    Gachályi A; Naményi J; Szegedi I; Varga LP
    Radiat Res; 1987 Nov; 112(2):312-7. PubMed ID: 3685258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long term retention of 237Np in rats.
    Wirth R; Volf V
    Int J Radiat Biol Relat Stud Phys Chem Med; 1984 Dec; 46(6):787-92. PubMed ID: 6335500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of 144Ce tissue deposition by mixed ligand complex treatment in mice.
    Gachályi A; Naményi J; Szegedi I; Varga PL
    Acta Physiol Hung; 1986; 68(3-4):233-40. PubMed ID: 3565034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mechanism of distribution of neptunium and plutonium in rats].
    Zhuravleva AK
    Radiobiologiia; 1984; 24(5):679-82. PubMed ID: 6505161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mobilization of lead by calcium versenate and dimercaptosuccinate in the rat.
    Tandon SK; Singh S; Prasad S; Mathur N
    Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):686-92. PubMed ID: 9750957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decorporating efficacy of catecholaminocarboxylate chelating agents for thorium-234 and protective effects on associated radiation injury.
    Chen H; Luo M; Sun M; Hu Y; Wang Y; Jin M; Cheng W
    Int J Radiat Biol; 2005 Apr; 81(4):309-18. PubMed ID: 16019940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral chelation treatment of injected 241Am or 239Pu in rats.
    Taylor DM; Volf V
    Health Phys; 1980 Feb; 38(2):147-58. PubMed ID: 7372481
    [No Abstract]   [Full Text] [Related]  

  • 38. Reduction of lead retention by mono-3-methylbutan-1-yl meso-2,3-dimercaptosuccinate in suckling rats.
    Blanusa M; Kostial K; Piasek M; Jones MM; Singh PK
    Analyst; 1995 Mar; 120(3):951-3. PubMed ID: 7741262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. INTERACTIONS IN THE METABOLISM OF PU-239 AND NP-239. HW-80500.
    SMITH VH
    HW SA US At Energy Comm; 1964 Jan; 18():73-5. PubMed ID: 24547246
    [No Abstract]   [Full Text] [Related]  

  • 40. Three plutonium chelation cases at Los Alamos National Laboratory.
    Bertelli L; Waters TL; Miller G; Gadd MS; Eaton MC; Guilmette RA
    Health Phys; 2010 Oct; 99(4):532-8. PubMed ID: 20838095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.